Bernie Sanders says a lot of stuff out there on the campaign trail to fire up his supporters.
At a recent event in Los Angeles, he hit on an issue that’s a high priority for both civil libertarians and criminal justice reform advocates alike: marijuana legalization.
The reaction from the more sanctimonious sectors of Legal Twitter started ripping Sanders for not understanding legal basics. There were a lot of cracks about how executive authority works and administrative law and even federalism. What most of these folks missed though was that Sanders is… mostly right about all of this.
While it may pain lawyers and quasi-lawyers, the first step to untangling the Sanders position is getting past semantics. Can a president legalize drugs by “Executive Order”? Not really. Can a president, through his or her executive authority, order this to happen? Yeah, pretty much. Once you’re not hung up on the Executive Order term of art this isn’t particularly controversial. The Controlled Substances Act defers authority to the Executive Branch to determine where specific drugs are scheduled and, by extension, just how much of a federal crime you’re committing when you’re using. [Read more at Above The Law]
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
Watching Santa Ana, California-based Unrivaled Brands (OTCQX: UNRV) compete in this market reminds me of the movie Memento, where memoryless Guy Pearce literally experiences the action unfold along with the rest of us, even though it’s his story and he’s the only one in it living life essentially in reverse. Similarly, and this may indeed…
LOS ANGELES (AP) — The U.S.′ expanding legal marijuana market is helping drive strong sales and profit growth for multistate operators like Trulieve Cannabis Corp. The Quincy, Florida-based company sells cannabis products in 11 states from Arizona to Pennsylvania. It reported $408.9 million in revenue in the first half of this year, an 89% jump…
A new research report from New Frontier Data, Cannabis and Wellness, a New Consumer Paradigm, challenges the existing framework of the cannabis market and expands it from a two-segment medical and adult-use (recreational) market to a three-segment market. In keeping with changing consumer perceptions and lessening social stigmas related to cannabis across age groups, the…
In a sign that Europe’s cannabis market is gaining traction, the Frankfurt-based operator of a website that pairs patients with marijuana-prescribing doctors has closed a seed funding round while adding one of the industry’s biggest-name executives to its board. The Bloomwell Group, a holding company for the marijuana telemedicine platform Algea Care, obtained more than…